Early molecular response of marrow disease to biologic therapy is highly prognostic in neuroblastoma Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Bone Marrow Neoplasms
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Immunoglobulin G
  • N-Acetylgalactosaminyltransferases
  • Neuroblastoma

abstract

  • GD2 synthase mRNA is a sensitive response marker of neuroblastoma in the bone marrow. It is particularly useful for minimal residual disease evaluation and may potentially be useful as an early predictor of resistance to antibody plus GM-CSF immunotherapy.

publication date

  • October 15, 2003

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2003.11.077

PubMed ID

  • 14551304

Additional Document Info

start page

  • 3853

end page

  • 8

volume

  • 21

number

  • 20